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B ullous p e mphigoid is assoc iate d wit h d e position of 
IgG a nd C 3 a t the d e rmal-epide rmal junction. In order 
to see w h e the r complement a ctivation in bullous p e m-
phigoid res ulted in d e position of membrane a ttack com-
p lex (M A C ) a t the b a seme nt membra ne zone, skin biop-
s ies from patie n ts with bullous p e mphigoid were e x am-
ine d using a direct immunofluorescence t echnique. By 
e mploy ing a monoclonal a n t ibody to a n e oantigen of C9, 
the MAC w a s d e monstra ted in linear pattern at the 
b asem e n t m e mbrane zone . These deposits were seen in 
bot h involved and uninv olve d s kin but the amount of 
MAC was g r eater in involved skin a s judged b y intens ity 
o f stain in g . S tipple d d e posits of MAC w ere also present 
in or a r ound e pide rmal b a sal cells . The MAC could be 
gen e r ated in vi t ro b y reac tion of normal pla sma with 
a n t ibasem e n t m embrane antibody bound to s ections o f 
monkey esophagus . The I gG antibody a ctivate d comple-
m e nt a nd this compleme nt a ctivation proceeded all the 
way to the termina l ste p. 
B ullous pemphi goid is a subepiderma l bullous disease asso-
ciated wit h deposit io n of IgG at t he derma l-epide rma l junct ion 
[1]. T hese a n t ibasemen t memb rane antibodies can fi x comple-
ment a nd lead to t he deposition of complemen t components 
such as Clq, properdin , a nd C3 [2- 5]. 
A pathogenic role of complem en t in blister production see ms 
like ly . Com plemen t is act ivated at t he exact s ite of bli ster 
fo rmation at t he dermal-epiderma l junction , a nd levels of var-
ious co mplemen t compon ents a re dec reased in blist e r fluid 
when compa red to se rum levels [5,6]. F urt hermore, blister fluid 
is chemotactic for polym o rp honuclear leukocytes, a nd t he 
chemotactic factor in blister flu id is p roba bly C5a [7]. 
While it is possible t h at blisters resu lt from degradative 
e nzymes re leased from neut rophils or eosinophils, a direct 
cytotox ic role fo r comple ment is possible. Assembly of t he 
membra ne attac k co mp lex (MAC) wi t h complemen t activa tion 
can cause lys is o f cell membranes [8]. 
W e used a m onoclona l a n t ibody to a neoan t igen of t he C9 
port ion of MAC to see whether comple men t activation in 
b ullous pemphigoid resu lted in M AC deposit ion at t he base-
m en t membra ne zo ne in vivo and assembly of MAC in vitro. 
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METHODS 
S ubjects 
All patients had tense bullae a rising on normal or erythematous 
skin . Pathologic examination of biopsy tissue showed subepidermal 
blisters with neutrophils and eosinophi ls within the bullae and in t he 
dermis. T he diagnosis was confi rmed by the finding of linea r deposits 
of lgG , C3 , or both at t he dermal-epidermal junction of periles ional or 
normal skin. 
Serum and T issue 
Serum was obtained from 4 patients. All sera conta ined lgG anti-
bodies which reacted with the basement membrane zone of stratified 
squamous epithelium as determined by indirect immunoflu orescence. 
Serum was frozen and stored at -20'C. The t ite rs of ant ibase mem 
membrane zone ant ibodies for in vitro experiments described below 
were 1:640, 1:320, 1:1280, and 1:1280. 
Biopsies were obta ined from 6 subjects, punch biopsies (3 mm) of 
involved peribullous skin (3 ) or normal sk in (3) were snap-frozen in 
liquid ni t rogen, and stored at -70' C un til tested. Monkey esopharus 
was obtained at necropsy. The esophagus was snap-frozen and sto;ed 
in liquid ni t rogen. 
Immunofluorescence 
Direct and indirect immunofluorescence were used to demonstrate 
antibody as previously described [9]. 
In order to dete rmine whether the MAC was deposited, a monoclonal 
antibody to a neoantigen of C9 was used in a two-step immunofluores-
cence techn ique on biopsy material. In addit ion, this reagent was used 
to demonstrate generation of the antigen following incubation of t issue 
with bullous pemphigoid sera in vi t ro. 
The production and characterization of t his monoclonal antibody 
(poly C9- MA) has been described previously [10] . It recognizes a 
neoant igen of C9, not present on monomeric C9, but common to both 
the isolated MAC and to polymerized C9. Anti-C5 ant ibody was used 
in parallel studies to ensure t hat t he ent ire MAC had been deposited. 
Previous studies have documented the homology in t issue of staining 
poly C9- MA with sites that reacted wi th goat antisera to tbe individual 
complement components C5, C6, C7, C8, and C9 [10] . 
Four-micron sections of t issue were immersed in phosphate-buffered 
saline (PBS) for 10 min , overlaid with poly C9- MA di luted 1:10 with 
PBS, and incubated for 30 min at 25'C in a moist chamber. Sections 
were washed for 15 min and t hen incubated wi th fluorescein-isothio-
cyanate (FITC)-labeled goat antimouse IgG (95% -y chain specific) 
(Accurate Chemical, Westbury, New York) for 30 min . Cross-reacting 
antihuman lgG had been removed by prior absorp tion wi th normal 
human plasma. The final ant ibody t ite r was 10; i.e. , 10 1-'g of antigen 
combi ned with 1 ml of antibody. 
Similarly, t issues were stained with goat-ant ihuman C5 (absorbed 
with C5-deficient human serum) followed by FITC-labeled rabbi t an-
t igoat IgG (Cappel Laboratories, Westchester, New York ), previously 
absorbed with normal human plasma. Other t issues were similarly 
stained with fluorescein-labeled goat-ant ihuman C3. The sections were 
washed in PBS fo r 45 min, mounted in phosphate-buffered glycerin, 
and examined with a Leitz immunoflu orescence microscope equipped 
with a vertical illuminator, a BP 450-490 NM excite r fi lter, and a LP 
520 NM barrier fi lte r. 
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As further evidence that the neoant igen of C9 could be deposited at 
the dermal-epidermal junction of skin of patients with bullous pem-
phigoid, complement was allowed to be act ivated by ant ibasement 
membrane zone antibodies in vi t ro. Four-micron sections of monkey 
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esophagus were immersed in verona! buffer containing 4% bovine 
serum albumin (VB) and overlaid wit h serum from each of 4 patients 
with bullous pemphigoid, eac h diluted 1:10 in VB. The ability of these 
sera to provide a source of complement had been destroyed by heating 
at 56"C for 30 min. Following incubation in a moist cha mber at 25"C 
for 30 min, the sections were washed by immersing in VB for 15 min . 
Complement activation was allowed to proceed by incubat ion with 
human plasma diluted 1:5 in VB. The presence of newly formed MAC 
was detected by incubating sections with poly C9- MA di luted 1:10 in 
VB, followed by washing for 15 min in VB, incubation for 30 min in 
absorbed FITC-labeled goat anti mouse conjugate (1:10), and then wash-
ing for 45 min in VB. Sections were examined by flu orescence micros-
copy as described above. 
Controls for in vitro formation of the MAC utilized the following 
reagents: 
1. Heat- inactivated normal human serum substituted for heat inacti-
vated sera from patients wi th bullous pemphigoid in the first step. 
2 . H eat-inactivated (56· C X 30 min) fresh human plasma substitu ted 
fo r fresh human plasma in the second step. 
3 . Fresh huma n plasma in which complement activation had been 
blocked wi t h MgEGTA (15 mM EGTA, 0.5 mM Mg++) prior to the 
second incubation. 
4. Fresh human p lasma in which complement activation had been 
blocked with EDTA (10 mM) prior to the second incubation. 
5. Plasma from a patient with C2 deficiency [llj substituted for fresh 
human plasma in t he second step. 
6. Substitution of VB for poly C9-MA in the t hird step. 
RESULTS 
The MAC was detected in skin from all patients with bullous 
pemphigoid in linea r array at the basement membrane zo ne 
(Fig 1). The pattern was indistinguishable from the pattern of 
lgG and C3 detected by direct immunofluorescence. While 
MAC was seen in specimens from both involved and clinically 
normal skin, t he intensity of sta ining was greater in involved 
s kin . .Stippled deposits of the MAC were present in or around 
epidermal basal cells in involved skin from one patient. 
MAC was generated in vitro by reaction of normal human 
plasma with antibasemen t membrane antibody bound to sec-
tions of monkey esophagus. The pattern of deposits was linea r 
(Figs 2, 3) and was indistinguishable from the pattern observed 
by indirect immunofluorescence for lgG or C3 when sera from 
F rG l. Membrane attack complex is present along the basement 
membrane zone and in basa l ce lls (arrows) of epidermis from patients 
with bullous pemphigoid (identified by poly C9- MA, x 160). 
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FIG 2. Membrane attack complex can be assembled at t he basemen! 
membrane zone in vitro (a rrow) (poly C9-MA, X 40). 
FIG 3. The deposits of membrane attack complex form a linear 
array (arrow). The fluorescent mate rial in t he dermis is elastic t issue 
which is autofluorescent (X 160). 
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TABLE I. Summary of indirect immunofluorescence studies 
Serum Complement AnLibody Linea r 
specimen source reage nt deposits 
BP NHS IgG + 
BP NHS C3 + 
BP NHS C5 + 
BP NHS Poly C9- MA + 
NHS NHS IgG 
NHS NHS C3 
NHS NHS C5 
NHS NI-lS Poly C9-MA 
BP NHS (heat inactivated) C3 
BP NI-18 (heat inactivated) Poly C9-MA 
BP NHS with MgEGTA C3 
BP NHS with MgEGTA Poly C9-MA 
BP NHS with EDTA C3 
BP NHS with EDTA Poly C9-MA 
BP C2 deficient C3 
BP C2 deficient Poly C9-MA 
BP NHS Verona! buffer 
BP = Bu llous pemphigoid (heat inactivated at 56"C for 30 min); 
NHS = normal human serum; EGTA = ethyleneglycoltetraacetate; 
EDTA = ethylenediam inetetraacetate. 
patients with bullous pemphigoid were used as a source of 
antibody. No deposits were seen when heat-inactivated normal 
sera were incubated with bullous pemphigoid se ra . Similarly, 
no deposits were seen when complement activation was blocked 
by heating, addit ion of MgEDTA or EDTA, or by use of C2-
deii cient serum. Also, no specific flu orescence was seen when 
poly C9-MA was om itted (Table I) . 
DISCUSSION 
Complement-induced membrane damage is mediated when 
the 5 terminal complement components assemble a fte r cleavage 
of C5 to C5a and C5b. C6, C7, and C8 attach to C5b to form 
the C5b6, C5b67, and C5b678 in termediates. Cell -bound C5b-8 
causes C9 to undergo polymerization and conformational 
changes wh ich a lter its antigenicity [10,12,13]. 
Detection of the neoantige n of t he MAC or of poly C9 with 
poly C9-MA implies t hat complemen t activation has proceeded 
to completion . T he presence of C5 in the same locus a nd pattern 
supports t he view that MAC had been assembled [10]. 
Bullous pemphigoid is characterized by subepidermal bu ll ae, 
and activation of complement at t he basement membrane zone 
of skin. T he pathogenic role of complement as a mediator of 
bliste r formation is unproved but seems likely. Activation of 
complement ge nerates C5a a nd other chemotactic molecul es 
which attract polymorphonuclear leukocytes to t his region. 
These liberated proteolytic enzymes may lead to dermal-epi-
de rmal separation. Recently, Gammon and associates have 
been able to induce separation of dermis from the epidermis in 
t issue sections by incubat ing a suspension of polymorphonu-
clear leukocytes with tissue sections conta ining pemphigoid 
antibody a nd complemen t [14- 16). 
Complement could a lso play a direct role in mediating dam-
age to t he basement membrane zone. In some patients, bullae 
ar ise from relatively uninflamed skin and the inflammatory 
in fi ltrate underl ying t he bullae is relatively devoid of inflam-
matory cells. At least in t hese bullae, a causal role of inflam-
matory cell s seems less likely. Here a nd in other bullae, com-
plement may mediate t he damage. Electron microscopy of 
pemphigoid bullae demonstrates abnormalities at t he basement 
membrane zone [17- 19). These abnormalities may have been 
caused directly by complemen t, or by mediators released from 
adjacent t issue by the MAC. 
In support of a pathogenic role for complement in the pro-
duction of the bullae of bullous pemphigoid , we found t he MAC 
at t he dermal -epidermal junction of sk in from patients in a 
linear pattern which mirrored IgG and C3 deposition. Using 
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direct immunofluorescence, t he intensity of stai ning was gen -
erally greater in biopsies of involved skin when compa red to 
biopsies from clinically normal skin . This implies that la r ger 
amounts of MAC are present at sites of bulla formaton. 
The MAC was a lso detected in or a round epiderma l basal 
cells of one patient (Fig 1) . This stippled fluorescence was 
limited to t he basal cells t hemselves, and no deposits were 
detected in kera t inocytes above t his laye r. The s ignifica nce of 
these deposits is unknown. 
We were also able to generate MAC in vitro by reacti ng tissue 
sections of epit helium with sera from patients with bullous 
pemphigoid to a llow binding of IgG ant ibody with the basement 
membrane zo ne. When fresh human plasma was added, com-
plement activation proceeded so t hat C3 and t he MAC could 
be detected at the basement membrane zone. The linea r pattern 
of MAC deposits we obse rved is analogous to the linea r patte r n 
of IgG observed by ordinary indirect immunofluorescence using 
t hese sera and FITC-labeled ant ihuman lgG. This patte rn was 
always linea r and unin te rrupted, a lthough t he intensity of 
flu orescence varied. 
Generation of the MAC was blocked by both EDTA and 
MgEGTA a nd by using C2-defic ient serum. This suggests t hat 
steps leading to MAC asse mbly can procede t hrough t he c las-
sical complement pat hway exclusively, at least in vitro. How-
ever, Jordon et a l previously detected properdin at t he basement 
membrane zone using s imilar methods [20]. This implied acti-
vation of the alternative pathway as well. 
Although the role of complement in bullous pemphigoid is 
still uncertain , t he detection of t he MAC aggregates in skin of 
patients with bullous pemphigoid a nd t he assembly of the MAC 
in vitro using serum from patients wi t h bullous pemphigoid 
demonstrate t hat complement activation proceeds to t he ter-
minal step. 
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